James H. Sabry, Director at CYTOKINETICS INC (CYTK), sold 54,000 shares at $3.00 ($164K) on 2009-12-15, disclosed to the SEC on 2009-12-17.
Open-market sale of $164k CYTK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.00 | 900 | $3K | 1.6% |
| 2 | $3.01 | 2,500 | $8K | 4.6% |
| 3 | $3.02 | 1,400 | $4K | 2.6% |
| 4 | $3.03 | 200 | $606 | 0.4% |
| 5 | $3.04 | 1,500 | $5K | 2.8% |
| 6 | $3.05 | 7,100 |
| $22K |
| 13.2% |
| 7 | $3.05 | 500 | $2K | 0.9% |
| 8 | $3.06 | 2,356 | $7K | 4.4% |
| 9 | $3.06 | 300 | $918 | 0.6% |
| 10 | $3.06 | 200 | $612 | 0.4% |
| 11 | $3.07 | 4,044 | $12K | 7.6% |
| 12 | $3.08 | 3,000 | $9K | 5.6% |
| 13 | $3.09 | 3,634 | $11K | 6.8% |
| 14 | $3.10 | 3,000 | $9K | 5.7% |
| 15 | $3.11 | 1,700 | $5K | 3.2% |
| 16 | $3.12 | 1,866 | $6K | 3.5% |
| 17 | $3.13 | 300 | $939 | 0.6% |
| 18 | $2.95 | 200 | $590 | 0.4% |
| 19 | $2.96 | 4,000 | $12K | 7.2% |
| 20 | $2.97 | 2,300 | $7K | 4.2% |
| 21 | $2.98 | 1,050 | $3K | 1.9% |
| 22 | $2.99 | 2,566 | $8K | 4.7% |
| 23 | $3.00 | 2,584 | $8K | 4.7% |
| 24 | $3.01 | 1,696 | $5K | 3.1% |
| 25 | $3.02 | 1,000 | $3K | 1.8% |
| 26 | $3.03 | 2,504 | $8K | 4.6% |
| 27 | $3.04 | 1,600 | $5K | 3.0% |
| Total | $3.04 avg | 54,000 | $164K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |